Show simple item record

dc.contributor.authorHuh, Yang Hoon
dc.contributor.authorKweon, Hee-Seok
dc.contributor.authorKitazawa, Toshio
dc.date2022-08-11T08:08:29.000
dc.date.accessioned2022-08-23T15:57:01Z
dc.date.available2022-08-23T15:57:01Z
dc.date.issued2013-10-24
dc.date.submitted2014-03-14
dc.identifier.citationHuh et al. ROCK inhibitor, Y-27632, reduces FBSinduced structural alteration in organ-cultured mesenteric artery. Journal of Analytical Science and Technology 2013, 4:15. doi:10.1186/2093-3371-4-15. <a href="http://dx.doi.org/10.1186/2093-3371-4-15">Link to article on publisher's website</a>
dc.identifier.doi10.1186/2093-3371-4-15
dc.identifier.pmid21643972
dc.identifier.urihttp://hdl.handle.net/20.500.14038/30099
dc.description.abstractBackground Chronic treatment with fetal bovine serum (FBS) causes gradual vasoconstriction, vascular wall thickening, and contractility reduction in organ-cultured vascular tissues. We have previously demonstrated that Rho-associated kinase (ROCK) inhibitors prevent the functional alterations of small arteries in response to the FBS treatment. Here, we tested a further hypothesis that the chronic inhibition of ROCK has a protective effect on FBS-induced structural alterations. Methods To verify the new hypothesis, the rabbit mesenteric arterial rings were cultured in FBS-supplemented culture medium with or without Y-27632, a reversible ROCK inhibitor and then western blot, immunohistochemistry, apoptosis assay, and electron microscopy were performed using organ-cultured arterial rings. Results Chronic treatment with Y-27632 maintained the arterial diameter by preventing FBS-induced gradual arterial constriction during organ culture. Y-27632 also reduced the apoptosis and the loss of contractile myosin and actin filaments of smooth muscle cells. In addition, Y-27632 protected the morphological integrity between the endothelial cell layer and smooth muscle cell layer by preventing endothelial cell detachment and platelet endothelial cell adhesion molecule (PECAM) expression decrement. Conclusions Chronic ROCK inhibition provides protective effects against FBS-stimulated structural in addition to functional alterations of vascular smooth muscle cells and endothelial cells. These results strongly suggest that the RhoA/ROCK signaling is crucial for maintaining the structural and functional phenotypes of vasculature, and hence, chronic ROCK inhibition may provide protective effects on excessive growth factor-related vascular diseases including hypertension and atherosclerosis.
dc.language.isoen_US
dc.rightsCopyright 2013 Huh et al.; licensee Springer. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.subjectCardiovascular disease
dc.subjectArtery
dc.subjectFetal bovine serum
dc.subjectOrgan culture
dc.subjectRhoA/ROCK signaling
dc.subjectCardiovascular Diseases
dc.subjectCellular and Molecular Physiology
dc.titleROCK inhibitor, Y-27632, reduces FBS-induced structural alteration in organ-cultured mesenteric artery
dc.typeJournal Article
dc.source.journaltitleJournal of Analytical Science and Technology
dc.source.volume4
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1334&amp;context=faculty_pubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/faculty_pubs/334
dc.identifier.contextkey5335052
refterms.dateFOA2022-08-23T15:57:01Z
html.description.abstract<p><strong>Background</strong></p> <p>Chronic treatment with fetal bovine serum (FBS) causes gradual vasoconstriction, vascular wall thickening, and contractility reduction in organ-cultured vascular tissues. We have previously demonstrated that Rho-associated kinase (ROCK) inhibitors prevent the functional alterations of small arteries in response to the FBS treatment. Here, we tested a further hypothesis that the chronic inhibition of ROCK has a protective effect on FBS-induced structural alterations.</p> <p><strong>Methods</strong></p> <p>To verify the new hypothesis, the rabbit mesenteric arterial rings were cultured in FBS-supplemented culture medium with or without Y-27632, a reversible ROCK inhibitor and then western blot, immunohistochemistry, apoptosis assay, and electron microscopy were performed using organ-cultured arterial rings.</p> <p><strong>Results</strong></p> <p>Chronic treatment with Y-27632 maintained the arterial diameter by preventing FBS-induced gradual arterial constriction during organ culture. Y-27632 also reduced the apoptosis and the loss of contractile myosin and actin filaments of smooth muscle cells. In addition, Y-27632 protected the morphological integrity between the endothelial cell layer and smooth muscle cell layer by preventing endothelial cell detachment and platelet endothelial cell adhesion molecule (PECAM) expression decrement.</p> <p><strong>Conclusions</strong></p> <p>Chronic ROCK inhibition provides protective effects against FBS-stimulated structural in addition to functional alterations of vascular smooth muscle cells and endothelial cells. These results strongly suggest that the RhoA/ROCK signaling is crucial for maintaining the structural and functional phenotypes of vasculature, and hence, chronic ROCK inhibition may provide protective effects on excessive growth factor-related vascular diseases including hypertension and atherosclerosis.</p>
dc.identifier.submissionpathfaculty_pubs/334
dc.contributor.departmentDepartment of Microbiology and Physiological Systems
dc.source.pages15


Files in this item

Thumbnail
Name:
jast_huh_2093_3371_4_15.pdf
Size:
2.375Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record